Renal hemodynamic effects in patients with moderate to severe heart failure during chronic treatment with trandolapril

Cardiovascular Drugs and Therapy

Volumn 12, Issue 4, 1998, Pages 395-403

  Van Der Ent, M ^a   Remme, W J ^a   De Leeuw, P W ^a   Bartels, G L ^a  

^a Sticares Cardiovascular Research Foundation   (Netherlands)

Author keywords

ACE inhibitors; Heart failure; Long term treatment; Neurohormones; Renal function; Trandolapril

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROHORMONE; NORADRENALIN; RENIN; TRANDOLAPRIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INDEX; HEART PRELOAD; HEART RATE; HEART STROKE VOLUME; HEART WORK; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; SYSTEMIC VASCULAR RESISTANCE; TIME; URINE OSMOLALITY;

AGED; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DIGOXIN; DIURETICS; EPINEPHRINE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; INDOLES; KIDNEY; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PULMONARY WEDGE PRESSURE; RENAL CIRCULATION; RENIN; TIME FACTORS;

EID: 0031723691     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007729002821     Document Type: Article

References (22)

1. Guidelines on treatment of heart failure. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 1997;18:736-753.
2. Curtiss C, Cohn JN, Vrobel T, Franciosa JA. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978;58:763-770
3. Gavras H, Faxon DP, Berkoben J, Brunner HR, Ryan TJ. Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation 1978;58:770-776.
4. Captopril Multicenter Research Group I. A cooperative multicenter study of captopril in congestive heart failure: Hemodynamic effects and long-term response. J Am Coll Cardiol 1983;2:755-763.
5. Creager MA, Massie BM, Faxon DP, et al. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol 1985;6:163-73.
6. Packer M, Lee WH, Yushak M, Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986;315:847-853.
7. Ljungman S, Kjekshus J, Swedberg K for the CONSENSUS Trial Group. Renal function in congestive heart failure during treatment with enalapril. Am J Cardiol 1992;70: 479-487.
8. Chevillard C, Brown NL, Jouquey S, Mathieu MN, Laliberte F, Hamon G. Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1989;14:297-301.
9. Richer C, Doussau MP, Giudicelli JF. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat. Am J Cardiol 1987;59:12D-17D
10. Fornes P, Richer C, Pussard E, Heudes D, Domergue V, Giudicelli JF. Beneficial effects of trandolapril on experimentally induced congestive heart failure in rats. Am J Cardiol 1992;70:43D-51D
11. The TRAndolapril Cardiac Evaluation (TRACE) study: Rationale, design, and baseline characteristics of the screened population. The Trace Study Group. Am J Cardiol 1994;73: 44C-50C.
12. Kober L, Torp-Pedersen C, Carlsen JE. et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-1676
13. Callahan AJ, Frelich JJ, McKusick KA, Leppo W, Strauss HW. A modified method for the in vivo labelling of red blood cells with Tc99m. J Nucl Med 1982;23:315-318.
14. Duarte CG. Renal Function Tests. Boston: Little Brown, 1980.
15. O'Reilly PH, Shields RA, Testa HJ. Nuclear Medicine in Urology and Nephrology. London: Butterworths, 1979.
16. Endert E. Determination of noradrenaline and adrenaline in plasma by a radio-enzymatic assay using high pressure liquid chromatography for the separation of the radiochemical products. Clin Chim Acta 1979;96:233-239.
17. Skinner SL, Cran EJ, Gibson R, Taylor R, Walters WAW, Catt KJ. Angiotensin I and II, active and inactive renin, renin substrate, renin activity and angiotensinase in human liquor amnii and plasma. Am J Obstet Gyneacol 1975;121:626-630.
18. Lijnen P, Amery AK, Fagard RH, Katz FH. Radioimmunoassay of angiotensin II in unextracted plasma. Clin Chim Acta 1978;88:403-412.
19. Uretsky BF, Shaver JA, Liang CS, et al. Modulation of hemodynamic effects with a converting enzyme inhibitor: Acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses. Am Heart J 1988;116:480-488.
20. Crozier IG, Ikram H, Nicholls MG, Jans S. Global and regional hemodynamic effects of ramipril in congestive heart failure. J Cardiovasc Pharmacol 1989;14:688-693.
21. Kubo SH. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure. Circulation 1990;81(Suppl.):III107-III114.
22. Swedberg K. Effects of ACE-inhibition on regional circulation in congestive heart failure. Acta Med Scand Suppl 1986; 707:91-93.